The hospital-acquired infection control market will touch USD 34,909.7 million by 2030, driven at a rate of 1.6%. The industry advance will be powered by the growing count of surgical procedures, increasing consciousness of environmental and personal hygiene, and rising chronic disease prevalence.

All patients who are hospitalized are vulnerable to contracting a nosocomial infection. Young children, the aged, and people with a weak immune system are more vulnerable to HAIs than others.

Thus, disinfection is a popular procedure, with an over 68% market share in the past, with hospitals trying to lower the rates of HAIs. HAI symptoms can appear in two–three days after a patient's hospital admission and continue for up to 10 days post discharge. For preventing these infections, the acceptance of disinfection is on the rise. Some widely used disinfectants for preventing the spread of nosocomial infections are glutaraldehyde, formaldehyde, and hydrogen peroxide.